Ambar protein industries Limited has submitted its quarterly compliance certificate to BSE for the quarter ended 31st March 2026, fulfilling regulatory requirements under SEBI's depository regulations. The submission, dated 09th April 2026, addresses the company's compliance with securities handling procedures during Q4FY26.

Regulatory Compliance Certificate

The certificate was issued under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018. This regulation mandates companies to provide confirmation regarding the proper handling of securities received for dematerialization during each quarter.

Registrar Confirmation

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, serves as the company's registrar and share transfer agent. The registrar provided comprehensive confirmation dated 01st April 2026 regarding securities handling during the quarter.

The registrar confirmed several key compliance aspects:

• Securities received from depository participants for dematerialization were properly confirmed to depositories
• All securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
• Security certificates received for dematerialization were appropriately confirmed or rejected
• Received certificates were mutilated and cancelled after due verification by depository participants
• Depository names were substituted in the register of members as registered owners within prescribed timelines

Company Information

Ambar Protein Industries Limited operates from its facility located at Plot No. 351, 353, 358, opposite Bhagyoday Hotel, Sarkhej-Bavla Highway, Changodar, Ta. Sanand, Dist. Ahmedabad, Gujarat. The company maintains its corporate identification number as L15400GJ1992PLC018758 and operates under Ahmedabad jurisdiction.

Regulatory Significance

This quarterly compliance certificate demonstrates the company's adherence to SEBI's depository regulations, ensuring transparency in securities handling and maintaining investor confidence. The timely submission reflects proper corporate governance practices and regulatory compliance management by the company's compliance officer.

Ambar Protein Industries Limited has disclosed that its promoter Pradeep Kumar Chunilal Khetani has acquired additional equity shares in the company through open market transactions. The latest acquisition was completed on March 05, 2026, following a previous acquisition in February 2026, with both transactions being reported to BSE Limited in compliance with regulatory requirements.

Latest Transaction Details

The most recent share acquisition involved 5,190 equity shares, representing 0.09% of the company's total share capital. The transaction was executed through open market purchase on March 05, 2026.

Updated Shareholding Pattern

Following the latest acquisition, Khetani's shareholding in Ambar Protein Industries has increased from 11.87% to 11.96%. This represents a cumulative increase from his earlier holding of 11.60% in February 2026.

Previous Acquisition History

In February 2026, Khetani had acquired 15,748 equity shares representing 0.27% of the company's share capital through open market transactions conducted on February 26 and 27, 2026. This had increased his shareholding from 11.60% to 11.87%.

Company Share Capital Structure

Ambar Protein Industries Limited maintains a stable equity share capital structure. The company's total equity share capital remains unchanged at INR 5,75,00,000, consisting of 57,50,000 equity shares with a face value of INR 10 each.

Regulatory Compliance

The disclosure has been filed under Regulation 29(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. As a promoter of the company, Khetani is required to disclose any changes in his shareholding pattern to ensure transparency for investors and market participants. The company's shares are listed on BSE Limited under script code 519471.